Ignite Creation Date:
2024-05-06 @ 11:02 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03410992
Status:
COMPLETED
Last Update Posted:
2023-12-20
First Post:
2018-01-19
Brief Title:
A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-05
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-19
First Submit QC Date:
January 19 2018
Study First Post Date:
2018-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-03-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2020-01-06
Disp First Submit QC Date:
February 9 2022
Disp First Post Date:
2022-03-04
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-12-15
Last Update Post Date:
2023-12-20
Last Update Post Date Type:
ACTUAL